1 |
J. Bajorath, "Integration of virtual and high-throughput screening", Nature Rev. Drug Discov., Vol. 1, pp. 882-894, 2002.
DOI
ScienceOn
|
2 |
W. P. Walters, M. T. Stahl, and M. A. Murcko, "Virtual screening-an overview", Drug Discov. Today, Vol. 3, pp. 160-178, 1998.
DOI
ScienceOn
|
3 |
T. Langer and R. D. Hoffmann, "Virtual screening: an effective tool for lead structure discovery", Curr. Pharm. Design., Vol. 7, pp. 509-527, 2001.
DOI
ScienceOn
|
4 |
H. Gohlke and G. Klebe, "Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors", Angew. Chem. Int. Ed., Vol. 41, pp. 2644- 2676, 2002.
DOI
|
5 |
I. D. Kuntz, J. M. Blaney, S. J. Oatley, R. Langridge, and T. E. Ferrin, "A geometric approach to macromolecule- ligand interactions", J. Mol. Biol., Vol. 161, pp. 269-288, 1982.
DOI
|
6 |
M.V. Itzstein, W.Y.Wu, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jin, T. V. Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn, "Rational design of potent sialidase-based inhibitors of influenza virus replication", Nature, Vol. 363, pp. 418- 423, 2002.
|
7 |
E. Garman and G. Laver, "Controlling influenza by inhibiting the virus's neuraminidase", Curr. Drug Targets, Vol. 2, pp. 119-136, 2004.
|
8 |
E. Kellenberger, J. Rodrigo, P. Muller, and D. Rognan, "Comparative evaluation of eight docking tools for docking and virtual screening accuracy", Proteins, Vol. 1, pp. 225-242, 2004.
|
9 |
H. Chen, P. D. Lyne, F. Giordanetto, T. Lovell, and J. Li, "On evaluating molecular-docking methods for pose prediction and enrichment factors", J. Chem. Inf. Model, Vol. 46, pp. 401-415, 2006.
DOI
ScienceOn
|
10 |
M. Stahl and M. Rarey, "Detailed analysis of scoring functions for virtual screening", J. Med. Chem., Vol. 44, pp. 1035-1042, 2001.
DOI
ScienceOn
|
11 |
K. M. Masukawa, P. A. Kollman, and I. D. Kuntz, "Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations", J. Med. Chem., Vol. 46, pp. 5628-5637, 2003.
DOI
ScienceOn
|
12 |
M. J. Groot, "Development of a combined protein and pharmacophore model for cytochrome P450 2C9", J. Med. Chem., Vol. 45, pp. 1983-1993, 2002.
DOI
ScienceOn
|
13 |
R. Sheridan, M. K. Holloway, G. B. McGaughey, R. T. Mosley, and S. B. Singh, "A simple method for visualizing the differences between related receptor sites", J. Mol. Graph. Model, Vol. 21, pp. 71-79, 2002.
DOI
ScienceOn
|
14 |
M. J, Groot, M. J. Ackland, V. A. Horne, A. A. Alex, and B. C. Jones, "Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6", J. Med. Chem., Vol. 42, pp. 1515- 1524, 1999.
DOI
ScienceOn
|
15 |
M. J, Groot, M. J. Ackland, V. A. Horne, A. A. Alex, and B. C. Jones, "A approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed n-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6", J. Med. Chem., Vol. 42, pp. 4062-4070, 1999.
DOI
ScienceOn
|
16 |
J. Y. Park and D. Harris, "Construction and assessment of models of CYP2E1: Predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations", J. Med. Chem., Vol. 46, pp. 1645-1660, 2003.
DOI
ScienceOn
|